Income Statement
CELLECTAR BIOSCIENCES, INC.
CLRB
Performance Overview
Click any row in the table to add it to this chart
in millions USD
| Metric | Dec 31, 2025 2025 FY | Dec 31, 2024 2024 FY | Dec 31, 2023 2023 FY | Dec 31, 2022 2022 FY | Dec 31, 2021 2021 FY | Dec 31, 2020 2020 FY | Dec 31, 2019 2019 FY | Dec 31, 2018 2018 FY | Dec 31, 2017 2017 FY | Dec 31, 2016 2016 FY | Dec 31, 2015 2015 FY | Dec 31, 2014 2014 FY | Dec 31, 2013 2013 FY | Dec 31, 2012 2012 FY | Dec 31, 2011 2011 FY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Revenue
|
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
|
Cost of Revenue
|
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
|
Gross Profit
|
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
|
Operating Expenses
|
22.98 | 51.78 | 38.96 | 28.81 | 24.13 | 15.29 | 14.18 | 11.66 | 13.60 | 9.45 | 8.55 | 9.67 | 11.30 | 8.75 | 6.29 |
|
Research & Development
|
11.50 | 26.14 | 28.21 | 19.22 | 17.59 | 10.14 | 9.00 | 6.84 | 9.47 | 4.75 | 5.16 | 5.96 | 6.86 | 5.12 | 3.60 |
|
Selling, General & Administrative
|
11.48 | 25.64 | 10.75 | 9.59 | 6.54 | 5.15 | 5.18 | 4.82 | 4.14 | 4.70 | 3.40 | 3.70 | 4.44 | 3.63 | 2.69 |
|
Other Operating Expenses
|
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
|
Operating Income
|
-22.98 | -51.78 | -38.96 | -28.81 | -24.13 | -15.29 | -14.18 | -11.66 | -13.60 | -9.45 | -8.55 | -9.67 | -11.30 | -8.75 | -6.29 |
|
Non-Operating Income
|
1.19 | 7.26 | 0.92 | 0.15 | 0.01 | 0.20 | 0.09 | 0.09 | 0.04 | 3.27 | 3.26 | 1.78 | 1.62 | -0.04 | -0.40 |
|
Interest Income
|
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
|
Interest Expense
|
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
|
Other Non-Op Income / Expense
|
- | - | - | - | - | - | - | - | - | - | - | - | 0.00 | 0.00 | - |
|
Income Before Tax
|
-21.79 | -44.52 | -38.04 | -28.66 | - | - | - | - | - | - | - | - | - | - | - |
|
Income Tax Expense
|
0.00 | 0.07 | -0.06 | -0.06 | - | - | - | - | - | - | - | - | - | - | - |
|
Non-Controlling Interest
|
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
|
Net Income
|
-21.79 | -44.58 | -37.98 | -28.60 | -24.12 | -15.09 | -14.09 | 0.00 | 0.00 | 0.00 | -5.50 | -8.11 | -10.78 | -8.80 | -7.44 |
Supplemental
Per share data, derived & other items — not part of the income statement
in millions USD unless noted
| Metric | Dec 31, 2025 2025 FY | Dec 31, 2024 2024 FY | Dec 31, 2023 2023 FY | Dec 31, 2022 2022 FY | Dec 31, 2021 2021 FY | Dec 31, 2020 2020 FY | Dec 31, 2019 2019 FY | Dec 31, 2018 2018 FY | Dec 31, 2017 2017 FY | Dec 31, 2016 2016 FY | Dec 31, 2015 2015 FY | Dec 31, 2014 2014 FY | Dec 31, 2013 2013 FY | Dec 31, 2012 2012 FY | Dec 31, 2011 2011 FY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Depreciation & Amortization
|
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
|
EBITDA
|
-22.77 | -51.49 | -38.77 | -28.67 | -24.13 | -15.15 | -14.05 | -11.57 | -12.05 | -9.09 | -8.19 | -9.30 | -10.88 | -8.26 | -5.71 |
|
Earnings Per Share (Basic)
|
-8.35 | -1.22 | -3.11 | -4.05 | -0.43 | - | - | - | - | - | - | - | - | - | - |
|
Diluted EPS
|
-8.35 | -1.40 | -3.11 | -4.05 | -0.76 | - | - | - | - | - | - | - | - | - | - |
|
Weighted Average Shares
|
2.61 | 36.62 | 12.22 | 7.06 | 55.52 | - | - | - | - | - | - | - | - | - | - |
|
Diluted Weighted Avg Shares
|
2.61 | 37.14 | 12.22 | 7.06 | 55.52 | - | - | - | - | - | - | - | - | - | - |
|
Comprehensive Income
|
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - |